当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析

恩华药业

(002262)

  

流通市值:188.36亿  总市值:216.46亿
流通股本:8.84亿   总股本:10.16亿

恩华药业(002262)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.18亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益834549.77万元,未分配利润663878.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产964263.84万元,负债129714.07万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,610,251,670.325,911,188,872.184,470,988,804.693,010,121,701.84
营业总成本1,251,661,776.484,768,546,017.033,262,994,941.652,233,759,335.62
其他经营收益
营业利润357,179,657.591,199,172,212.531,245,304,994.17792,856,298.15
利润总额355,723,802.831,173,082,351.131,233,557,232.01788,404,080.87
净利润317,601,675.651,054,901,758.251,104,525,768.28700,054,285.99
每股收益
其他综合收益--1,986,860.16--
综合收益总额317,601,675.651,052,914,898.091,104,525,768.28700,054,285.99
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,874,617,689.796,462,952,432.66,649,180,742.496,369,176,126.17
非流动资产:
非流动资产合计2,768,020,698.032,760,279,487.562,430,509,294.222,419,348,793.38
资产总计9,642,638,387.829,223,231,920.169,079,690,036.718,788,524,919.55
流动负债:
流动负债合计1,207,335,486.621,092,239,535.19912,185,100.581,052,735,115.17
非流动负债:
非流动负债合计89,805,192.76103,096,352.1891,948,246.1890,768,427.73
负债合计1,297,140,679.381,195,335,887.371,004,133,346.761,143,503,542.9
所有者权益(或股东权益):
归属于母公司股东权益合计8,374,548,528.428,057,134,574.758,103,884,269.777,672,267,779.43
股东权益合计8,345,497,708.448,027,896,032.798,075,556,689.957,645,021,376.65
负债和股东权益合计9,642,638,387.829,223,231,920.169,079,690,036.718,788,524,919.55
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,516,171,770.386,433,556,634.044,928,567,517.593,180,488,495.51
经营活动现金流出小计1,358,342,141.55,355,166,877.214,017,420,960.642,685,665,296.19
经营活动产生的现金流量净额157,829,628.881,078,389,756.83911,146,556.95494,823,199.32
投资活动产生的现金流量:
投资活动现金流入小计1,591,215,444.746,863,707,235.345,860,271,003.584,416,678,965.76
投资活动现金流出小计1,796,135,996.947,425,643,800.195,889,834,306.434,116,883,442.53
投资活动产生的现金流量净额-204,920,552.2-561,936,564.85-29,563,302.85299,795,523.23
筹资活动产生的现金流量:
筹资活动现金流入小计61,000,00030,000,00040,000,00040,000,000
筹资活动现金流出小计38,126,739.71416,097,700.19450,077,661.04397,433,644.08
筹资活动产生的现金流量净额22,873,260.29-386,097,700.19-410,077,661.04-357,433,644.08
汇率变动对现金及现金等价物的影响668,615.1-1,036,094.54222,198.59524,324.56
现金及现金等价物净增加额-23,549,047.93129,319,397.25471,727,791.65437,709,403.03
期末现金及现金等价物余额1,319,232,629.291,342,781,677.221,685,190,071.621,651,171,683
补充资料:
现金及现金等价物的净增加额-129,319,397.25-437,709,403.03
最新报告期:2026-05-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
野村东方国际证券孔令岩1.131.301.482026-05-07
华西证券崔文亮,程仲瑶1.311.491.642026-04-23
华泰证券代雯,李奕玮1.161.341.522026-04-19
TOP↑